The emerging importance of tranexamic acid in dermatology

Summary Tranexamic acid (TA) is an antifibrinolytic agent, increasingly recognized as being of utility for a wide variety of skin diseases. We review the evidence supporting the use of TA for a range of dermatological indications, including (among others) melasma, postinflammatory hyperpigmentation,...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental dermatology Vol. 45; no. 4; pp. 445 - 449
Main Authors Forbat, E., Al‐Niaimi, F., Ali, F.R.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.06.2020
Subjects
Antifibrinolytic agents
Edema
Hyperpigmentation
Skin diseases
Urticaria
Online AccessGet full text

Cover

More Information
Summary:Summary Tranexamic acid (TA) is an antifibrinolytic agent, increasingly recognized as being of utility for a wide variety of skin diseases. We review the evidence supporting the use of TA for a range of dermatological indications, including (among others) melasma, postinflammatory hyperpigmentation, urticaria, angio‐oedema and haemostasis, in addition to practical considerations of its use by dermatologists. Click here for the corresponding questions to this CME article.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0307-6938
1365-2230
DOI:10.1111/ced.14115